Selected research
Market Outlook & Growth Opportunities
Global Biological Evaluation Services Market Outlook and Growth Opportunities 2026
Market perspective
The global Biological Evaluation Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Biological Evaluation Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Biological Evaluation Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Biological Evaluation Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Biological Evaluation Services market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Biological Evaluation Services market include Charles River Laboratories, Labcorp, Namsa, SGS SA, TVU SUD, SenzaGen, LFH Regulatory, Med Institute and SCC Medical Devices, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Biological Evaluation Services market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Biological Evaluation Services and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Biological Evaluation Services revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Biological Evaluation Services market.
Biological Evaluation Services Segment by Company
Charles River Laboratories
Labcorp
Namsa
SGS SA
TVU SUD
SenzaGen
LFH Regulatory
Med Institute
SCC Medical Devices
Measurlabs
Sushvin
GBA Key2Compliance
Qserve
Thinqbetter
Groenakker
JordiLabs, LLC
Biotox Laboratories
Gnovo
Yimeida Meoical Device Consulting
Prima Drug Research Center
Mid Link
WuXi AppTec Medical Device Testing Center
Biological Evaluation Services Segment by Type
Toxicology Evaluation
Safety Pharmacology
Immunology Evaluation
Others
Biological Evaluation Services Segment by Application
Drugs
Medical Devices
Diagnostic Reagents
Biomaterials
Others
Biological Evaluation Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Biological Evaluation Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Biological Evaluation Services key companies, revenue, market share, and recent developments.
3. To split the Biological Evaluation Services breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Biological Evaluation Services market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Biological Evaluation Services significant trends, drivers, influence factors in global and regions.
6. To analyze Biological Evaluation Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biological Evaluation Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biological Evaluation Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biological Evaluation Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Biological Evaluation Services industry.
Chapter 3: Detailed analysis of Biological Evaluation Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Biological Evaluation Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Biological Evaluation Services in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
List of Tables
Table 1. Biological Evaluation Services Industry Trends
Table 2. Biological Evaluation Services Industry Drivers
Table 3. Biological Evaluation Services Industry Opportunities and Challenges
Table 4. Biological Evaluation Services Industry Restraints
Table 5. Global Biological Evaluation Services Revenue by Company (US$ Million) & (2021-2026)
Table 6. Global Biological Evaluation Services Revenue Share by Company (2021-2026)
Table 7. Global Biological Evaluation Services Company Ranking, (2024-2026) & (US$ Million)
Table 8. Global Biological Evaluation Services Key Company Manufacturing Base & Headquarters
Table 9. Global Biological Evaluation Services Company, Product Type & Application
Table 10. Global Biological Evaluation Services Company Establishment Date
Table 11. Global Company Market Concentration Ratio (CR5 and HHI)
Table 12. Global Biological Evaluation Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025)
Table 13. Mergers & Acquisitions, Expansion
Table 14. Significant Companies of Toxicology Evaluation
Table 15. Significant Companies of Safety Pharmacology
Table 16. Significant Companies of Immunology Evaluation
Table 17. Significant Companies of Others
Table 18. Global Biological Evaluation Services Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million)
Table 19. Global Biological Evaluation Services Sales Value by Type (2021-2026) & (US$ Million)
Table 20. Global Biological Evaluation Services Sales Value by Type (2027-2032) & (US$ Million)
Table 21. Global Biological Evaluation Services Sales Value Share by Type (2021-2026)
Table 22. Global Biological Evaluation Services Sales Value Share by Type (2027-2032)
Table 23. Significant Companies of Drugs
Table 24. Significant Companies of Medical Devices
Table 25. Significant Companies of Diagnostic Reagents
Table 26. Significant Companies of Biomaterials
Table 27. Significant Companies of Others
Table 28. Global Biological Evaluation Services Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million)
Table 29. Global Biological Evaluation Services Sales Value by Application (2021-2026) & (US$ Million)
Table 30. Global Biological Evaluation Services Sales Value by Application (2027-2032) & (US$ Million)
Table 31. Global Biological Evaluation Services Sales Value Share by Application (2021-2026)
Table 32. Global Biological Evaluation Services Sales Value Share by Application (2027-2032)
Table 33. Global Biological Evaluation Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Table 34. Global Biological Evaluation Services Sales Value by Region (2021-2026) & (US$ Million)
Table 35. Global Biological Evaluation Services Sales Value Share by Region (2021-2026)
Table 36. Global Biological Evaluation Services Sales Value by Region (2027-2032) & (US$ Million)
Table 37. Global Biological Evaluation Services Sales Value Share by Region (2027-2032)
Table 38. Global Biological Evaluation Services Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 39. Global Biological Evaluation Services Sales Value by Country (2021-2026) & (US$ Million)
Table 40. Global Biological Evaluation Services Sales Value Market Share by Country (2021-2026)
Table 41. Global Biological Evaluation Services Sales Value by Country (2027-2032) & (US$ Million)
Table 42. Global Biological Evaluation Services Sales Value Market Share by Country (2027-2032)
Table 43. Charles River Laboratories Company Information
Table 44. Charles River Laboratories Business Overview
Table 45. Charles River Laboratories Biological Evaluation Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 46. Charles River Laboratories Biological Evaluation Services Product Portfolio
Table 47. Charles River Laboratories Recent Development
Table 48. Labcorp Company Information
Table 49. Labcorp Business Overview
Table 50. Labcorp Biological Evaluation Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 51. Labcorp Biological Evaluation Services Product Portfolio
Table 52. Labcorp Recent Development
Table 53. Namsa Company Information
Table 54. Namsa Business Overview
Table 55. Namsa Biological Evaluation Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 56. Namsa Biological Evaluation Services Product Portfolio
Table 57. Namsa Recent Development
Table 58. SGS SA Company Information
Table 59. SGS SA Business Overview
Table 60. SGS SA Biological Evaluation Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 61. SGS SA Biological Evaluation Services Product Portfolio
Table 62. SGS SA Recent Development
Table 63. TVU SUD Company Information
Table 64. TVU SUD Business Overview
Table 65. TVU SUD Biological Evaluation Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 66. TVU SUD Biological Evaluation Services Product Portfolio
Table 67. TVU SUD Recent Development
Table 68. SenzaGen Company Information
Table 69. SenzaGen Business Overview
Table 70. SenzaGen Biological Evaluation Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 71. SenzaGen Biological Evaluation Services Product Portfolio
Table 72. SenzaGen Recent Development
Table 73. LFH Regulatory Company Information
Table 74. LFH Regulatory Business Overview
Table 75. LFH Regulatory Biological Evaluation Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 76. LFH Regulatory Biological Evaluation Services Product Portfolio
Table 77. LFH Regulatory Recent Development
Table 78. Med Institute Company Information
Table 79. Med Institute Business Overview
Table 80. Med Institute Biological Evaluation Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 81. Med Institute Biological Evaluation Services Product Portfolio
Table 82. Med Institute Recent Development
Table 83. SCC Medical Devices Company Information
Table 84. SCC Medical Devices Business Overview
Table 85. SCC Medical Devices Biological Evaluation Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 86. SCC Medical Devices Biological Evaluation Services Product Portfolio
Table 87. SCC Medical Devices Recent Development
Table 88. Measurlabs Company Information
Table 89. Measurlabs Business Overview
Table 90. Measurlabs Biological Evaluation Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 91. Measurlabs Biological Evaluation Services Product Portfolio
Table 92. Measurlabs Recent Development
Table 93. Sushvin Company Information
Table 94. Sushvin Business Overview
Table 95. Sushvin Biological Evaluation Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 96. Sushvin Biological Evaluation Services Product Portfolio
Table 97. Sushvin Recent Development
Table 98. GBA Key2Compliance Company Information
Table 99. GBA Key2Compliance Business Overview
Table 100. GBA Key2Compliance Biological Evaluation Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 101. GBA Key2Compliance Biological Evaluation Services Product Portfolio
Table 102. GBA Key2Compliance Recent Development
Table 103. Qserve Company Information
Table 104. Qserve Business Overview
Table 105. Qserve Biological Evaluation Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 106. Qserve Biological Evaluation Services Product Portfolio
Table 107. Qserve Recent Development
Table 108. Thinqbetter Company Information
Table 109. Thinqbetter Business Overview
Table 110. Thinqbetter Biological Evaluation Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 111. Thinqbetter Biological Evaluation Services Product Portfolio
Table 112. Thinqbetter Recent Development
Table 113. Groenakker Company Information
Table 114. Groenakker Business Overview
Table 115. Groenakker Biological Evaluation Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 116. Groenakker Biological Evaluation Services Product Portfolio
Table 117. Groenakker Recent Development
Table 118. JordiLabs, LLC Company Information
Table 119. JordiLabs, LLC Business Overview
Table 120. JordiLabs, LLC Biological Evaluation Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 121. JordiLabs, LLC Biological Evaluation Services Product Portfolio
Table 122. JordiLabs, LLC Recent Development
Table 123. Biotox Laboratories Company Information
Table 124. Biotox Laboratories Business Overview
Table 125. Biotox Laboratories Biological Evaluation Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 126. Biotox Laboratories Biological Evaluation Services Product Portfolio
Table 127. Biotox Laboratories Recent Development
Table 128. Gnovo Company Information
Table 129. Gnovo Business Overview
Table 130. Gnovo Biological Evaluation Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 131. Gnovo Biological Evaluation Services Product Portfolio
Table 132. Gnovo Recent Development
Table 133. Yimeida Meoical Device Consulting Company Information
Table 134. Yimeida Meoical Device Consulting Business Overview
Table 135. Yimeida Meoical Device Consulting Biological Evaluation Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 136. Yimeida Meoical Device Consulting Biological Evaluation Services Product Portfolio
Table 137. Yimeida Meoical Device Consulting Recent Development
Table 138. Prima Drug Research Center Company Information
Table 139. Prima Drug Research Center Business Overview
Table 140. Prima Drug Research Center Biological Evaluation Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 141. Prima Drug Research Center Biological Evaluation Services Product Portfolio
Table 142. Prima Drug Research Center Recent Development
Table 143. Mid Link Company Information
Table 144. Mid Link Business Overview
Table 145. Mid Link Biological Evaluation Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 146. Mid Link Biological Evaluation Services Product Portfolio
Table 147. Mid Link Recent Development
Table 148. WuXi AppTec Medical Device Testing Center Company Information
Table 149. WuXi AppTec Medical Device Testing Center Business Overview
Table 150. WuXi AppTec Medical Device Testing Center Biological Evaluation Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 151. WuXi AppTec Medical Device Testing Center Biological Evaluation Services Product Portfolio
Table 152. WuXi AppTec Medical Device Testing Center Recent Development
Table 153. Research Programs/Design for This Report
Table 154. Authors List of This Report
Table 155. Secondary Sources
Table 156. Primary Sources
List of Figures
Figure 1. Biological Evaluation Services Product Image
Figure 2. Global Biological Evaluation Services Market Size (US$ Million), 2021 VS 2025 VS 2032
Figure 3. Global Biological Evaluation Services Market Size (2021-2032) & (US$ Million)
Figure 4. Global Biological Evaluation Services Company Revenue Ranking in 2025 (US$ Million)
Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million)
Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 7. Toxicology Evaluation Image
Figure 8. Safety Pharmacology Image
Figure 9. Immunology Evaluation Image
Figure 10. Others Image
Figure 11. Global Biological Evaluation Services Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 12. Global Biological Evaluation Services Sales Value Share 2021 VS 2025 VS 2032
Figure 13. Global Biological Evaluation Services Sales Value Share by Type (2021-2032)
Figure 14. Drugs Image
Figure 15. Medical Devices Image
Figure 16. Diagnostic Reagents Image
Figure 17. Biomaterials Image
Figure 18. Others Image
Figure 19. Global Biological Evaluation Services Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 20. Global Biological Evaluation Services Sales Value Share 2021 VS 2025 VS 2032
Figure 21. Global Biological Evaluation Services Sales Value Share by Application (2021-2032)
Figure 22. Global Biological Evaluation Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Figure 23. Global Biological Evaluation Services Sales Value Share by Region: 2021 VS 2025 VS 2032
Figure 24. North America Biological Evaluation Services Sales Value (2021-2032) & (US$ Million)
Figure 25. North America Biological Evaluation Services Sales Value Share by Country (%), 2025 VS 2032
Figure 26. Europe Biological Evaluation Services Sales Value (2021-2032) & (US$ Million)
Figure 27. Europe Biological Evaluation Services Sales Value Share by Country (%), 2025 VS 2032
Figure 28. Asia-Pacific Biological Evaluation Services Sales Value (2021-2032) & (US$ Million)
Figure 29. Asia-Pacific Biological Evaluation Services Sales Value Share by Country (%), 2025 VS 2032
Figure 30. South America Biological Evaluation Services Sales Value (2021-2032) & (US$ Million)
Figure 31. South America Biological Evaluation Services Sales Value Share by Country (%), 2025 VS 2032
Figure 32. Middle East & Africa Biological Evaluation Services Sales Value (2021-2032) & (US$ Million)
Figure 33. Middle East & Africa Biological Evaluation Services Sales Value Share by Country (%), 2025 VS 2032
Figure 34. USA Biological Evaluation Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 35. USA Biological Evaluation Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 36. USA Biological Evaluation Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 37. Canada Biological Evaluation Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 38. Canada Biological Evaluation Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 39. Canada Biological Evaluation Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 40. Mexico Biological Evaluation Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 41. Mexico Biological Evaluation Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 42. Mexico Biological Evaluation Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 43. Germany Biological Evaluation Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 44. Germany Biological Evaluation Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 45. Germany Biological Evaluation Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 46. France Biological Evaluation Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 47. France Biological Evaluation Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 48. France Biological Evaluation Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 49. U.K. Biological Evaluation Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 50. U.K. Biological Evaluation Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 51. U.K. Biological Evaluation Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 52. Italy Biological Evaluation Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 53. Italy Biological Evaluation Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 54. Italy Biological Evaluation Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 55. Spain Biological Evaluation Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 56. Spain Biological Evaluation Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 57. Spain Biological Evaluation Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 58. Russia Biological Evaluation Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 59. Russia Biological Evaluation Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 60. Russia Biological Evaluation Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 61. Netherlands Biological Evaluation Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 62. Netherlands Biological Evaluation Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 63. Netherlands Biological Evaluation Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 64. Nordic Countries Biological Evaluation Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 65. Nordic Countries Biological Evaluation Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 66. Nordic Countries Biological Evaluation Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 67. China Biological Evaluation Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 68. China Biological Evaluation Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 69. China Biological Evaluation Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 70. Japan Biological Evaluation Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 71. Japan Biological Evaluation Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 72. Japan Biological Evaluation Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 73. South Korea Biological Evaluation Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 74. South Korea Biological Evaluation Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 75. South Korea Biological Evaluation Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 76. India Biological Evaluation Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 77. India Biological Evaluation Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 78. India Biological Evaluation Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 79. Australia Biological Evaluation Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 80. Australia Biological Evaluation Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 81. Australia Biological Evaluation Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 82. Southeast Asia Biological Evaluation Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 83. Southeast Asia Biological Evaluation Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 84. Southeast Asia Biological Evaluation Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 85. Brazil Biological Evaluation Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 86. Brazil Biological Evaluation Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 87. Brazil Biological Evaluation Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 88. Argentina Biological Evaluation Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 89. Argentina Biological Evaluation Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 90. Argentina Biological Evaluation Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 91. Chile Biological Evaluation Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 92. Chile Biological Evaluation Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 93. Chile Biological Evaluation Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 94. Colombia Biological Evaluation Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 95. Colombia Biological Evaluation Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 96. Colombia Biological Evaluation Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 97. Peru Biological Evaluation Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 98. Peru Biological Evaluation Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 99. Peru Biological Evaluation Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 100. Saudi Arabia Biological Evaluation Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 101. Saudi Arabia Biological Evaluation Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 102. Saudi Arabia Biological Evaluation Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 103. Israel Biological Evaluation Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 104. Israel Biological Evaluation Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 105. Israel Biological Evaluation Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 106. UAE Biological Evaluation Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 107. UAE Biological Evaluation Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 108. UAE Biological Evaluation Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 109. Turkey Biological Evaluation Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 110. Turkey Biological Evaluation Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 111. Turkey Biological Evaluation Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 112. Iran Biological Evaluation Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 113. Iran Biological Evaluation Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 114. Iran Biological Evaluation Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 115. Egypt Biological Evaluation Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 116. Egypt Biological Evaluation Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 117. Egypt Biological Evaluation Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 118. Years Considered
Figure 119. Research Process
Figure 120. Key Executives Interviewed
Scope & coverage.
Types
- Toxicology Evaluation
- Safety Pharmacology
- Immunology Evaluation
- Others
Applications
- Drugs
- Medical Devices
- Diagnostic Reagents
- Biomaterials
- Others
Companies covered
- Charles River Laboratories
- Labcorp
- Namsa
- SGS SA
- TVU SUD
- SenzaGen
- LFH Regulatory
- Med Institute
- SCC Medical Devices
- Measurlabs
- Sushvin
- GBA Key2Compliance
- Qserve
- Thinqbetter
- Groenakker
- JordiLabs, LLC
- Biotox Laboratories
- Gnovo
- Yimeida Meoical Device Consulting
- Prima Drug Research Center
- Mid Link
- WuXi AppTec Medical Device Testing Center
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Biological Evaluation Services Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Biological Evaluation Services Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Biological Evaluation Services Market Dynamics
- 2.1 Biological Evaluation Services Industry Trends
- 2.2 Biological Evaluation Services Industry Drivers
- 2.3 Biological Evaluation Services Industry Opportunities and Challenges
- 2.4 Biological Evaluation Services Industry Restraints
3 Biological Evaluation Services Market by Company
- 3.1 Global Biological Evaluation Services Company Revenue Ranking in 2025
- 3.2 Global Biological Evaluation Services Revenue by Company (2021-2026)
- 3.3 Global Biological Evaluation Services Company Ranking (2024-2026)
- 3.4 Global Biological Evaluation Services Company Manufacturing Base and Headquarters
- 3.5 Global Biological Evaluation Services Company Product Type and Application
- 3.6 Global Biological Evaluation Services Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Biological Evaluation Services Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Biological Evaluation Services Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Biological Evaluation Services Market by Type
- 4.1 Biological Evaluation Services Type Introduction
- 4.1.1 Toxicology Evaluation
- 4.1.2 Safety Pharmacology
- 4.1.3 Immunology Evaluation
- 4.1.4 Others
- 4.2 Global Biological Evaluation Services Sales Value by Type
- 4.2.1 Global Biological Evaluation Services Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Biological Evaluation Services Sales Value by Type (2021-2032)
- 4.2.3 Global Biological Evaluation Services Sales Value Share by Type (2021-2032)
5 Biological Evaluation Services Market by Application
- 5.1 Biological Evaluation Services Application Introduction
- 5.1.1 Drugs
- 5.1.2 Medical Devices
- 5.1.3 Diagnostic Reagents
- 5.1.4 Biomaterials
- 5.1.5 Others
- 5.2 Global Biological Evaluation Services Sales Value by Application
- 5.2.1 Global Biological Evaluation Services Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Biological Evaluation Services Sales Value by Application (2021-2032)
- 5.2.3 Global Biological Evaluation Services Sales Value Share by Application (2021-2032)
6 Biological Evaluation Services Regional Value Analysis
- 6.1 Global Biological Evaluation Services Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Biological Evaluation Services Sales Value by Region (2021-2032)
- 6.2.1 Global Biological Evaluation Services Sales Value by Region: 2021-2026
- 6.2.2 Global Biological Evaluation Services Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Biological Evaluation Services Sales Value (2021-2032)
- 6.3.2 North America Biological Evaluation Services Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Biological Evaluation Services Sales Value (2021-2032)
- 6.4.2 Europe Biological Evaluation Services Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Biological Evaluation Services Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Biological Evaluation Services Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Biological Evaluation Services Sales Value (2021-2032)
- 6.6.2 South America Biological Evaluation Services Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Biological Evaluation Services Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Biological Evaluation Services Sales Value Share by Country, 2025 VS 2032
7 Biological Evaluation Services Country-level Value Analysis
- 7.1 Global Biological Evaluation Services Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Biological Evaluation Services Sales Value by Country (2021-2032)
- 7.2.1 Global Biological Evaluation Services Sales Value by Country (2021-2026)
- 7.2.2 Global Biological Evaluation Services Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Biological Evaluation Services Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Biological Evaluation Services Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Biological Evaluation Services Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Biological Evaluation Services Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Biological Evaluation Services Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Biological Evaluation Services Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Biological Evaluation Services Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Biological Evaluation Services Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Biological Evaluation Services Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Biological Evaluation Services Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Biological Evaluation Services Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Biological Evaluation Services Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Biological Evaluation Services Sales Value Growth Rate (2021-2032)
- 7.7.2 France Biological Evaluation Services Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Biological Evaluation Services Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Biological Evaluation Services Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Biological Evaluation Services Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Biological Evaluation Services Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Biological Evaluation Services Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Biological Evaluation Services Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Biological Evaluation Services Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Biological Evaluation Services Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Biological Evaluation Services Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Biological Evaluation Services Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Biological Evaluation Services Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Biological Evaluation Services Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Biological Evaluation Services Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Biological Evaluation Services Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Biological Evaluation Services Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Biological Evaluation Services Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Biological Evaluation Services Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Biological Evaluation Services Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Biological Evaluation Services Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Biological Evaluation Services Sales Value Growth Rate (2021-2032)
- 7.14.2 China Biological Evaluation Services Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Biological Evaluation Services Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Biological Evaluation Services Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Biological Evaluation Services Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Biological Evaluation Services Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Biological Evaluation Services Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Biological Evaluation Services Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Biological Evaluation Services Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Biological Evaluation Services Sales Value Growth Rate (2021-2032)
- 7.17.2 India Biological Evaluation Services Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Biological Evaluation Services Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Biological Evaluation Services Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Biological Evaluation Services Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Biological Evaluation Services Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Biological Evaluation Services Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Biological Evaluation Services Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Biological Evaluation Services Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Biological Evaluation Services Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Biological Evaluation Services Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Biological Evaluation Services Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Biological Evaluation Services Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Biological Evaluation Services Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Biological Evaluation Services Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Biological Evaluation Services Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Biological Evaluation Services Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Biological Evaluation Services Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Biological Evaluation Services Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Biological Evaluation Services Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Biological Evaluation Services Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Biological Evaluation Services Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Biological Evaluation Services Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Biological Evaluation Services Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Biological Evaluation Services Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Biological Evaluation Services Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Biological Evaluation Services Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Biological Evaluation Services Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Biological Evaluation Services Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Biological Evaluation Services Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Biological Evaluation Services Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Biological Evaluation Services Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Biological Evaluation Services Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Biological Evaluation Services Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Biological Evaluation Services Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Biological Evaluation Services Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Biological Evaluation Services Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Biological Evaluation Services Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Biological Evaluation Services Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Biological Evaluation Services Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Biological Evaluation Services Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Biological Evaluation Services Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Charles River Laboratories
- 8.1.1 Charles River Laboratories Company Information
- 8.1.2 Charles River Laboratories Business Overview
- 8.1.3 Charles River Laboratories Biological Evaluation Services Revenue and Gross Margin (2021-2026)
- 8.1.4 Charles River Laboratories Biological Evaluation Services Product Portfolio
- 8.1.5 Charles River Laboratories Recent Developments
- 8.2 Labcorp
- 8.2.1 Labcorp Company Information
- 8.2.2 Labcorp Business Overview
- 8.2.3 Labcorp Biological Evaluation Services Revenue and Gross Margin (2021-2026)
- 8.2.4 Labcorp Biological Evaluation Services Product Portfolio
- 8.2.5 Labcorp Recent Developments
- 8.3 Namsa
- 8.3.1 Namsa Company Information
- 8.3.2 Namsa Business Overview
- 8.3.3 Namsa Biological Evaluation Services Revenue and Gross Margin (2021-2026)
- 8.3.4 Namsa Biological Evaluation Services Product Portfolio
- 8.3.5 Namsa Recent Developments
- 8.4 SGS SA
- 8.4.1 SGS SA Company Information
- 8.4.2 SGS SA Business Overview
- 8.4.3 SGS SA Biological Evaluation Services Revenue and Gross Margin (2021-2026)
- 8.4.4 SGS SA Biological Evaluation Services Product Portfolio
- 8.4.5 SGS SA Recent Developments
- 8.5 TVU SUD
- 8.5.1 TVU SUD Company Information
- 8.5.2 TVU SUD Business Overview
- 8.5.3 TVU SUD Biological Evaluation Services Revenue and Gross Margin (2021-2026)
- 8.5.4 TVU SUD Biological Evaluation Services Product Portfolio
- 8.5.5 TVU SUD Recent Developments
- 8.6 SenzaGen
- 8.6.1 SenzaGen Company Information
- 8.6.2 SenzaGen Business Overview
- 8.6.3 SenzaGen Biological Evaluation Services Revenue and Gross Margin (2021-2026)
- 8.6.4 SenzaGen Biological Evaluation Services Product Portfolio
- 8.6.5 SenzaGen Recent Developments
- 8.7 LFH Regulatory
- 8.7.1 LFH Regulatory Company Information
- 8.7.2 LFH Regulatory Business Overview
- 8.7.3 LFH Regulatory Biological Evaluation Services Revenue and Gross Margin (2021-2026)
- 8.7.4 LFH Regulatory Biological Evaluation Services Product Portfolio
- 8.7.5 LFH Regulatory Recent Developments
- 8.8 Med Institute
- 8.8.1 Med Institute Company Information
- 8.8.2 Med Institute Business Overview
- 8.8.3 Med Institute Biological Evaluation Services Revenue and Gross Margin (2021-2026)
- 8.8.4 Med Institute Biological Evaluation Services Product Portfolio
- 8.8.5 Med Institute Recent Developments
- 8.9 SCC Medical Devices
- 8.9.1 SCC Medical Devices Company Information
- 8.9.2 SCC Medical Devices Business Overview
- 8.9.3 SCC Medical Devices Biological Evaluation Services Revenue and Gross Margin (2021-2026)
- 8.9.4 SCC Medical Devices Biological Evaluation Services Product Portfolio
- 8.9.5 SCC Medical Devices Recent Developments
- 8.10 Measurlabs
- 8.10.1 Measurlabs Company Information
- 8.10.2 Measurlabs Business Overview
- 8.10.3 Measurlabs Biological Evaluation Services Revenue and Gross Margin (2021-2026)
- 8.10.4 Measurlabs Biological Evaluation Services Product Portfolio
- 8.10.5 Measurlabs Recent Developments
- 8.11 Sushvin
- 8.11.1 Sushvin Company Information
- 8.11.2 Sushvin Business Overview
- 8.11.3 Sushvin Biological Evaluation Services Revenue and Gross Margin (2021-2026)
- 8.11.4 Sushvin Biological Evaluation Services Product Portfolio
- 8.11.5 Sushvin Recent Developments
- 8.12 GBA Key2Compliance
- 8.12.1 GBA Key2Compliance Company Information
- 8.12.2 GBA Key2Compliance Business Overview
- 8.12.3 GBA Key2Compliance Biological Evaluation Services Revenue and Gross Margin (2021-2026)
- 8.12.4 GBA Key2Compliance Biological Evaluation Services Product Portfolio
- 8.12.5 GBA Key2Compliance Recent Developments
- 8.13 Qserve
- 8.13.1 Qserve Company Information
- 8.13.2 Qserve Business Overview
- 8.13.3 Qserve Biological Evaluation Services Revenue and Gross Margin (2021-2026)
- 8.13.4 Qserve Biological Evaluation Services Product Portfolio
- 8.13.5 Qserve Recent Developments
- 8.14 Thinqbetter
- 8.14.1 Thinqbetter Company Information
- 8.14.2 Thinqbetter Business Overview
- 8.14.3 Thinqbetter Biological Evaluation Services Revenue and Gross Margin (2021-2026)
- 8.14.4 Thinqbetter Biological Evaluation Services Product Portfolio
- 8.14.5 Thinqbetter Recent Developments
- 8.15 Groenakker
- 8.15.1 Groenakker Company Information
- 8.15.2 Groenakker Business Overview
- 8.15.3 Groenakker Biological Evaluation Services Revenue and Gross Margin (2021-2026)
- 8.15.4 Groenakker Biological Evaluation Services Product Portfolio
- 8.15.5 Groenakker Recent Developments
- 8.16 JordiLabs, LLC
- 8.16.1 JordiLabs, LLC Company Information
- 8.16.2 JordiLabs, LLC Business Overview
- 8.16.3 JordiLabs, LLC Biological Evaluation Services Revenue and Gross Margin (2021-2026)
- 8.16.4 JordiLabs, LLC Biological Evaluation Services Product Portfolio
- 8.16.5 JordiLabs, LLC Recent Developments
- 8.17 Biotox Laboratories
- 8.17.1 Biotox Laboratories Company Information
- 8.17.2 Biotox Laboratories Business Overview
- 8.17.3 Biotox Laboratories Biological Evaluation Services Revenue and Gross Margin (2021-2026)
- 8.17.4 Biotox Laboratories Biological Evaluation Services Product Portfolio
- 8.17.5 Biotox Laboratories Recent Developments
- 8.18 Gnovo
- 8.18.1 Gnovo Company Information
- 8.18.2 Gnovo Business Overview
- 8.18.3 Gnovo Biological Evaluation Services Revenue and Gross Margin (2021-2026)
- 8.18.4 Gnovo Biological Evaluation Services Product Portfolio
- 8.18.5 Gnovo Recent Developments
- 8.19 Yimeida Meoical Device Consulting
- 8.19.1 Yimeida Meoical Device Consulting Company Information
- 8.19.2 Yimeida Meoical Device Consulting Business Overview
- 8.19.3 Yimeida Meoical Device Consulting Biological Evaluation Services Revenue and Gross Margin (2021-2026)
- 8.19.4 Yimeida Meoical Device Consulting Biological Evaluation Services Product Portfolio
- 8.19.5 Yimeida Meoical Device Consulting Recent Developments
- 8.20 Prima Drug Research Center
- 8.20.1 Prima Drug Research Center Company Information
- 8.20.2 Prima Drug Research Center Business Overview
- 8.20.3 Prima Drug Research Center Biological Evaluation Services Revenue and Gross Margin (2021-2026)
- 8.20.4 Prima Drug Research Center Biological Evaluation Services Product Portfolio
- 8.20.5 Prima Drug Research Center Recent Developments
- 8.21 Mid Link
- 8.21.1 Mid Link Company Information
- 8.21.2 Mid Link Business Overview
- 8.21.3 Mid Link Biological Evaluation Services Revenue and Gross Margin (2021-2026)
- 8.21.4 Mid Link Biological Evaluation Services Product Portfolio
- 8.21.5 Mid Link Recent Developments
- 8.22 WuXi AppTec Medical Device Testing Center
- 8.22.1 WuXi AppTec Medical Device Testing Center Company Information
- 8.22.2 WuXi AppTec Medical Device Testing Center Business Overview
- 8.22.3 WuXi AppTec Medical Device Testing Center Biological Evaluation Services Revenue and Gross Margin (2021-2026)
- 8.22.4 WuXi AppTec Medical Device Testing Center Biological Evaluation Services Product Portfolio
- 8.22.5 WuXi AppTec Medical Device Testing Center Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$4,250USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst